GSK image

GSK confirms hundreds of US job cuts

December 3, 2014
Medical Communications, Research and Development, Sales and Marketing Advair, GSK, Parexel, RTP, anoro, breo, job cuts, respiratory

GlaxoSmithKline has finally confirmed the rumours that it is cutting hundreds of US jobs as the UK firm struggles to …

Osborne and co image

UK budget sees R&D tax credits rise

December 3, 2014
Sales and Marketing Budget, Cameron, George Osborne, NHS, Whitehead, life sciences

Chancellor George Osborne has delivered the government’s 2014 Autumn Statement to the Commons which includes news of an increase in …

Evotec image

Evotec and Sanofi enter pre-clinical deal

December 3, 2014
Research and Development, Sales and Marketing DiaPep277, Evotec, Sanofi, oncology, priftin, toulouse

Evotec and Sanofi have entered negotiations for a major multi-component strategic alliance worth around €250 million over the next five …

Sepha award

Packaging machinery specialist, Sepha Ltd, Wins National Award for Excellence in Innovation

December 3, 2014

The Northern Ireland-based packaging machinery manufacturer, Sepha Ltd. has won the award for Excellence in Innovation from the UK Chamber …

NICE recommends test to reduce antibiotic use

December 3, 2014
Sales and Marketing Antibiotics, GPs, NICE, UK, doctors, icl, pneumonia

NICE guidelines say GPs should use point of care blood tests to assess which patients to prescribe antibiotics for bacterial …

Novartis image

Novartis flu vaccine cleared following safety probe

December 3, 2014
Sales and Marketing GSK, Novartis, Vaccine, flu, fluad

The Italian drugs safety agency has cleared the Novartis influenza vaccine Fluad, after an investigation found the vaccine was not …

Hunt image

Hunt sets out plans for expanded NHS budget

December 3, 2014
Sales and Marketing Budget, Hunt, NHS, UK, election, health, king's fund

Health secretary Jeremy Hunt has laid out his plans for the future of the NHS in a speech to parliament, …

Avanir image

Otsuka buys Avanir for $3.5 billion

December 3, 2014
Sales and Marketing Abilify, Alzheimer's, Alzheimer’s, Nuedexta, Otsuka, Parkinson's, Parkinson’s, avanir

Otsuka is to buy Avanir Pharmaceuticals for $3.5 billion as it looks to make up for the imminent patent expiry …

Lung xray image

‘Postcode lottery’ still cause of many lung cancer deaths

December 3, 2014
Research and Development, Sales and Marketing DoH, Roche, astranzeneca, lung cancer, nlca, oncology, pd-1

Patients are still pointlessly dying of lung cancer due to a ‘postcode lottery’ of services according to new results from …

andreas_pott_ema

EMA discussing executive director post

December 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Guido Rasi, andreas pott

The European Medicines Agency has confirmed that Andreas Pott will remain in charge of the body in place of the …

23andMe genome testing kit image

MHRA approves Google gene test for UK

December 2, 2014
Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, FDA, MHRA, UK, US, gene, google, test

The MHRA has approved a controversial genetic test for the UK – despite it being banned by the US FDA. …

Roche image

Roche buys Ariosa Diagnostics

December 2, 2014
Research and Development, Sales and Marketing IPF, IQuum, InterMune, Roche, ariosa, cfdna, diabetes, genia, seragon

Roche has purchased the privately-held US company Ariosa Diagnostics for an undisclosed fee as it looks to expand further into …

FDA image

FDA clears Sanofi TB drug indication

December 2, 2014
Research and Development, Sales and Marketing Bedaquiline, FDA, Sanofi, WHO, priftin, rifapentine, sirturo

The FDA has approved Sanofi’s Priftin for a new tuberculosis (TB) indication following a priority review from the regulator. Priftin …

Roche image

NICE U-turn on Roche leukaemia drug

December 2, 2014
Sales and Marketing Gazyvaro, MabThera, NHS, NICE, Roche, leukaemia, obinutuzumab

NICE has reversed its decision on Roche’s chronic lymphocytic leukaemia (CLL) drug Gazyvaro only two months after rejecting the drug. …

paolo_poletti_nucana

NuCana appoints GSK oncology head

December 2, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Paolo Paoletti, biomed, nucana

Edinburgh-based clinical stage biopharma firm NuCana BioMed has appointed Dr Paolo Paoletti to its board of directors.  Paoletti has been …

Lilly image

AZ and Lilly Alzheimer’s drug enters trials

December 1, 2014
Research and Development, Sales and Marketing AZD3293, Alzheimer's, AstraZeneca, LY3314814, lilly

AstraZeneca and Eli Lilly have begun a Phase II/II trial for their Alzheimer’s treatment AZD3293 as the companies hope to …

£2 billion government plan to ‘save the NHS’

December 1, 2014
Sales and Marketing Conservatives, NHS, Osborne, UK, balls, election, spending

George Osborne in his Autumn Statement on Wednesday will announce an extra £2 billion funding for the NHS in an attempt …

john_blakeley_crf_health

CRF Health expands leadership team

December 1, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing crf health, enbuska, john blakeley

Clinical trials e-solutions firm CRF Health has announced two new additions to the company’s executive leadership team. John Blakeley (pictured) …

Freeman image

George Freeman: UK pharma is vital for our landscape

December 1, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, WHO, freeman, medicine, stratified

The ABPI says the UK has an opportunity to benefit from stratified medicine, and the body’s 2014 conference held in …

BI image

Boehringer’s lung cancer drug Vargatef sees EU approval

November 28, 2014
Sales and Marketing Boehringer, EU, Europe, IPF, NSCLC, lung cancer, nintedanib, ofev, vargatef

Boehringer Ingelheim’s nintedanib has received its second nod in Europe this month with the European Commission approving it for the …

The Gateway to Local Adoption Series

Latest content